Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis. uri icon

authors

  • Fox, Robert J
  • Naismith, Robert T
  • Ashokkumar, Akshata
  • Barnes, Janel
  • Ecklund, Dixie
  • Klingner, Elizabeth
  • Koepp, Maxine
  • Long, Jeffrey D
  • Natarajan, Sneha
  • Thornell, Brenda
  • Yankey, Jon
  • Coffey, Christopher S
  • Bermel, Robert A
  • Debbins, Josef P
  • Huang, Xuemei
  • Jagodnik, Patricia
  • Lowe, Mark J
  • Nakamura, Kunio
  • Narayanan, Sridar
  • Sakaie, Ken E
  • Thoomukuntla, Bhaskar
  • Zhou, Xiaopeng
  • Conwit, Robin
  • Krieger, Stephen
  • Alvarez, Enrique
  • Apperson, Michelle
  • Bashir, Khurram
  • Cohen, Bruce A
  • Coyle, Patricia K
  • Delgado, Silvia
  • Dewitt, L Dana
  • Flores, Angela
  • Giesser, Barbara S
  • Cudkowicz, Merit E
  • Goldman, Myla D
  • Jubelt, Burk
  • Lava, Neil
  • Lynch, Sharon G
  • Moses, Harold
  • Ontaneda, Daniel
  • Perumal, Jai S
  • Racke, Michael
  • Repovic, Pavle
  • Riley, Claire S
  • Gleason, Trevis
  • Severson, Christopher
  • Shinnar, Shlomo
  • Suski, Valerie
  • Weinstock-Guttman, Bianca
  • Yadav, Vijayshree
  • Zabeti, Aram
  • Goodman, Andrew
  • Klawiter, Eric C
  • Matsuda, Kazuko
  • McGovern, Michelle

publication date

  • January 1, 2018